Episode 34: Why Nash Drug Trials Fail:A Thoughtful, Challenging Theory

Prof. Dr. Jörn M. Schattenberg joins the Surfers to discuss his recent article in Expert Opinion on Investigational Drugs dissecting recent drug trial failures.


 
Prof. Dr. Jörn M. Schattenberg g joins Stephen, Donna, Louise and Roger to discuss his recent article “The Nonalcoholic Steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future successes.” The discussion started with lessons from failed trials, focusing on the importance of utilizing Phase 2 trials to test hypotheses and establish appropriate targets. From there, Surfers went on to discuss commercial and patient-focused definitions of what makes a clinical trial successful.

Similar Episode Categories

SUBSCRIBE

Subscribe for free. New podcasts Wednesday Evening / Thursday Morning.

Apple
Spotify
Google
Stitcher
Buzzsprout
YouTube
SoundCloud

ASK

We record each week and answer your questions along with our focussed topics. To have your question answered in future episodes… 

CONNECT

Join The Discussion in our LinkedIn or Facebook Discussion Groups

Sign Up For Email Notifications when the next episode is available!

We record each week and answer your questions along with our focussed topics. To have your question answered in the future episode, submit your question no later than Tuesday afternoon by 2pm. You can also Tweet @HEPdyamics

Ask Our Panelists A Question…

Podcast Quesitonaire
Is your question directed towards one of our panelists?

If your question is answered in our next Podcast, would you like be tagged?

Surfing NASH Tsunami

Advance Notification

We send out emails to notify our followers before we post on social media, and often it's before your podcast app is updated!